Dermatology Devices Market Report Scope & Overview:

Get more information on Dermatology Devices Market - Request Sample Report

Dermatology Devices Market Size was valued at USD 15.2 Billion in 2023 and is expected to reach USD 40.56 Billion by 2032, growing at a CAGR of 11.54% over the forecast period 2024-2032. The dermatology devices market report includes the incidence and prevalence of key dermatology skin conditions and regional device volume trends. The report examines the adoption of innovative technologies in dermatology compared to other medical specialties, assesses and forecasts uptake of device-assisted treatments through prescribed and non-prescribed care, and quantifies facility, government, private, and out-of-pocket healthcare spending. The report also examines trends in regulatory compliance, including approvals from health authorities across the globe. This is a complete insight into market dynamics, it helps stakeholders identify shifts in demand, areas of high potential investment, and technological monitoring. Growing incidence of skin diseases and accelerating aesthetic procedures are the major factors that are estimated to boost the growth of the global dermatology devices market throughout the year. An estimated 900 million people globally are affected by some kind of skin disease according to the World Health Organisation, and the prevalence of skin diseases and conditions, including psoriasis, acne, and skin cancer, is rising.

Market Dynamics

Drivers

• Growing demand for aesthetic and cosmetic procedures is propelling the dermatology devices market.

The dermatology devices market is mainly driven by rising demand for aesthetic and cosmetic procedures. Both surgical and nonsurgical aesthetic procedures have shown a marked increase recently. As an example, the International Society of Aesthetic Plastic Surgery (ISAPS) observed an 11.2% increase in aesthetic procedures worldwide in 2022, reaching a total of 33.7 million (14.9 million surgical and 18.8 million non-surgical). Liposuction was the most performed surgical procedure 2.3 million and botulinum toxin injections were the top non-surgical procedure 9 million.  A survey revealed that 37% of respondents observed increased demand since the onset of the global pandemic. Factors such as heightened social media influence and the desire to look good on digital platforms contribute to this trend. A wider demographic, particularly men between the ages of 35-50 years opting for cosmetic procedures is also noticeable with a staggering 79% of respondents saying that they have seen an increase in male clients.

The 'luxury face' also rose to prominence, focusing on ways to enhance naturally using high-tech treatments. Now, this trend, which has the endorsements of celebrities, looks to be subtle, undetectable procedures typically used in a combo of injectables, lasers, and energy-based devices. This desire for high-end aesthetic results highlights an emerging trend in the market of expensive cosmetic procedures in patients with high spending power. This is critical to estimate a few more patterns incorporating vast and persistently existing demand for the aesthetic arrangements which offer a portion of the central core driving the dermatology devices market ahead.

Restraint

• Stringent regulatory requirements pose challenges to the dermatology devices market.

Stringent regulatory requirements pose a significant challenge to the dermatology devices market. In India, the Central Drugs Standard Control Organization (CDSCO) mandates rigorous safety and efficacy standards for medical devices, including those used in dermatology. The CDSCO evaluates the safety and performance criteria for every product, and only after that manufacturers receive approval for market access. Similarly, in China, companies are required to register their dermatology devices and obtain the Medical Device Registration Certificate, adhering to the Classification Catalogue of Medical Devices. It is a meticulous process that performs detailed assessments to ensure that the product will be safe and effective.

In Japan, manufacturers must secure SHONIN (marketing approval) from the Pharmaceuticals and Medical Devices Agency (PMDA) before commercializing their products. This review process involves rigorous evaluations to ensure that devices meet established safety and effectiveness standards before they can access the market. Although necessary to ensure patient safety, these stringent regulatory frameworks can make life difficult for manufacturers. This would eventually lead to heightened compliance costs and also delays in product launches owing to the complex approval processes. Consequently, companies must navigate these regulations carefully to ensure timely market entry and maintain competitiveness in the dermatology devices sector.

Opportunity:

• The rising demand for home-use dermatology devices presents a significant opportunity in the market.

Home-use dermatology devices provide substantial opportunities in the dermatology devices market. Consumers are increasingly favoring at-home beauty treatments over salon visits, leading to a surge in sales of beauty tech devices. The pandemic triggered this trend, which has only expanded since, paving the way for the use of LED beauty masks, microneedling at home, laser hair removal devices, hand-held massage guns, and many more electronic devices and electronic skin cleansers.

The beauty gadget market has significantly evolved, offering advanced at-home devices capable of delivering clinic-like results. Current popular devices include NuFace, Lyma Laser, and CurrentBody's LED face mask. The most recent innovations include Lightinderm's wand stick and Medicube Age-R Booster Pro combining serum application with a microcurrent mode. Additionally, there are also radio-frequency (RF) devices available, such as Anté Beauty's Kanyen RF Facial Device, that provide non-invasive alternatives to collagen stimulation and muscle activation. NASA technology improved for use by civilians, LED is a favorite among skin and hair enthusiasts alike, and leaders in space include Therabody's TheraFace Mask and Celluma's Restore. Regular use of these devices and the combining of treatment with appropriate skin care can create incredible beauty advantage. These devices are becoming more popular due to their convenience, affordability, and the need for skincare at home as it would be offered in a professional setting. As technology advances, home-use dermatology devices are becoming more sophisticated, offering users effective solutions for various skin concerns without the need for clinical visits.

Challenge:

• The lack of skilled personnel represents a significant restraint in the dermatology devices market.

The dermatology devices market faces a significant challenge due to a shortage of skilled professionals proficient in operating advanced equipment. This lack of availability reduces the appropriate use of laser and energy-based devices which require specialized training for safe and effective use. The complexity of these devices requires continuous education, but resource and time limitations frustrate healthcare providers' access to complete training programs. This problem is even more acute in rural and other underserved regions that may lack ready dermatological treatment. Tackling this problem is going to need plenty of focus and investing in training and education so that healthcare professionals can make effective use of more complex dermatology devices.

Segmentation Analysis

By Product

In 2023, treatment devices dominated and accounted for 78% revenue share. The commonness of skin ailments being one of the key motivations fuelling the development of this market, the U.S. National Institutes of Health has announced that yearly, more than 85 million Americans are influenced by skin infections. Such high prevalence demand for high end devices for treatment of dermatological conditions. Moreover, technological developments are also an important reason behind the domination of this segment. Advanced laser, radiofrequency and light-based technologies have led to unparalleled efficacy and outcomes. These breakthroughs have led to improved efficacy, safety, and comfort for patients during dermatologic procedures, making their adoption in clinical practice more relevant.

This segment is growing with the aid of government support. In recent years, several dermatological treatment devices have received approval from the U.S. Food and Drug Administration (FDA), which in turn helps in boosting the market growth by confirming the safety and effectiveness of these devices. With regulatory backing for the use of these devices in several skin treatments, both healthcare provider and patient confidence in using these devices have increased.

By Application

The hair removal applications segment accounted for the largest market share, in 2023, due to the increase in tattoo & pigmented lesion removal procedures performed, which are expected to contribute towards this segment's growth in dermatology devices. According to the International Society of Aesthetic Plastic Surgery (ISAPS), hair removal was one of the five most common non-invasive procedures worldwide in 2019, with 9.35 million treatments performed. They highlight an increasing interest from consumers towards permanent solutions for at-home hair removal. The progress in technology has contributed to the growth of the segment. Improvements in laser and light-based hair removal technologies have increased the effectiveness of laser hair removal while simultaneously decreasing treatment duration, making these procedures more appealing to consumers. These advancements have also made treatments more comfortable and suitable for a wider range of skin types and hair colors, expanding the potential customer base.

One of the reasons behind the segment has also been government regulations. There are many hair removal devices approved by the U.S. FDA for professional and home use that are safe and effective. This level of guidance has resulted in increased consumer confidence in these treatments. Moreover, increasing health awareness due to government-sponsored health education programs about hair removal procedures is another major factor, expected to boost the growth of the global hair removal market.

By End-Use

In 2023, the dermatology devices market was led by the hospital segment, which accounted for the largest market share of 54%. This dominance is largely due to a combination of several critical factors that ensure hospitals are the preferred option for dermatology treatments and procedures. Hospitals are generally complete care facilities, and as such, provide a broad range of dermatological services from diagnostics to complicated treatments. This ability to offer a full spectrum of care attracts a large patient base, as individuals can receive all necessary treatments in one location. The advanced infrastructure of hospitals also plays a crucial role. They are generally equipped with the latest dermatology apparatus, allowing them to offer advanced treatments which may not be offered in smaller clinics or private practice environments.

One more point that favors hospitals is insurance coverage. Hospital-based dermatologic care is better covered by many insurance plans, making it more affordable for patients. This includes coverage for both medically necessary and certain elective procedures, motivating patients to pursue treatment in a hospital. Hospitals must adhere to strict regulatory standards to ensure the safe and effective use of dermatology devices. Hence, the segment holds high market share, thanks to this commitment to quality and safety, which then leads to better trust from patients.

Regional Analysis

North America dominated the dermatology devices market in 2023, and held a market share of approximately 40%. Several important elements support this leadership position, establishing the region as a centre of excellence In dermatological care and innovation. The advanced healthcare infrastructure in North America, particularly in the United States and Canada, has been a primary driver of market dominance. These nations already have highly developed healthcare systems, with advanced dermatological technologies commonly embraced. This infrastructure enables new devices and treatments to be integrated with rapidity, keeping the region at the cutting edge of dermatological care. The dominance of North America in the dermatology R&D landscape has ensured its market share. The U.S. National Institutes of Health spent more than $300 million researching skin diseases, encouraging creativity and the formulation of novel therapies and technologies. This commitment to research ensures a continuous pipeline of advanced dermatological solutions.

The Asia-Pacific region is emerging as the fastest-growing market for dermatology devices. This rapid growth is driven by several factors, including a rapidly expanding healthcare infrastructure. Emerging economies such as China and India along with other developing countries are also deeply investing in healthcare development providing the dermatology devices market with new opportunities. As reported by the World Bank, growing disposable incomes in several Asian nations are contributing to making dermatological services quite affordable. This economic growth also allows a greater segment of the population to afford sophisticated skin care treatments and devices. Growing skin health and aesthetic procedure awareness initiated by government organizations in the Asia-Pacific region is expected to positively propel the market growth. The large patient pool in this densely populated region provides a substantial market for dermatology devices, attracting investments from global manufacturers.

Need any customization research on Dermatology Devices  Market - Enquiry Now

Recent Development

• In March 2024, The U.S. Food and Drug Administration approved the use of a new laser device treatment for acne scars, providing patients with a new way of treating this common skin issue.

• In February 2023, Candela Corporation announced Health Canada's licensure of Candela's Frax Pro non-ablative fractional laser and Nordlys multi-application platform with Selective Waveband Technology (SWT).

Key Players

Key Service Providers/Manufacturers

• Cutera, Inc. (truSculpt, Xeo)

• Lumenis Ltd. (Stellar M22, AcuPulse)

• Candela Medical (Vbeam Prima, GentleMax Pro)

• Alma Lasers (Harmony XL Pro, Soprano ICE)

• Fotona d.o.o. (Dynamis Pro, StarWalker)

• Sciton, Inc. (JOULE, BBL HERO)

• Solta Medical (Bausch Health) (Thermage FLX, Clear + Brilliant)

• Venus Concept Inc. (Venus Viva, Venus Legacy)

• Strata Skin Sciences (XTRAC, TheraClearX)

• Zimmer MedizinSysteme (Cryo 6, Z Wave)

Users

• Mayo Clinic

• Cleveland Clinic

• Johns Hopkins Dermatology and Cosmetic Center

• American Skin Institute

• Skin & Cancer Institute

• Westlake Dermatology & Cosmetic Surgery

• Advanced Dermatology and Cosmetic Surgery

• Dermatology Associates of Atlanta

• Mount Sinai Dermatology

• The Harley Street Dermatology Clinic